Gina Dapul-Hidalgo, MD
Allergy & Immunology · Rockville, MDNPI 1952592818
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,390, 2.9 times the $484 reported in 2019.
Across 182 payments — averaging $27.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$907
- Regeneron Healthcare Solutions, Inc.$695
- Sanofi$575
- Genentech USA, Inc.$391
- GSK$275
- Pfizer$265
- plus $2K from 21 others
What the payments were for
- Consulting fees$230%
- Food & beverage$4,96398%
- Education$882%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $907 |
| Regeneron Healthcare Solutions, Inc. | 27 | $695 |
| Sanofi | 19 | $575 |
| Genentech USA, Inc. | 12 | $391 |
| GSK | 14 | $275 |
| Pfizer | 12 | $265 |
| Greer Laboratories, Inc. | 1 | $248 |
| Alk-abello, Inc | 4 | $227 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $221 |
| Novartis | 4 | $209 |
| Grifols USA, LLC | 6 | $175 |
| Blueprint Medicines Corporation | 1 | $104 |
| Biocryst US Sales Co., LLC | 2 | $99 |
| Kaleo, Inc. | 6 | $96 |
| Optinose US, Inc. | 4 | $88 |
| Incyte Corporation | 3 | $77 |
| Sanofi-aventis U.S. LLC | 2 | $65 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $64 |
| Sanofi US Services Inc. | 1 | $55 |
| Lilly USA, LLC | 2 | $48 |
| Dermavant Sciences, Inc. | 1 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Pharming Healthcare, Inc. | 1 | $27 |
| USWM, LLC | 1 | $26 |
| ADMA Biomanufacturing LLC | 1 | $23 |
| Aerin Medical Inc. | 1 | $21 |
| Octapharma USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,074 in reported general payments places this provider in the 65th percentile of 105 allergy & immunology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Rockville
- Sudhir SekhsariaRockville$87K
- Kristin SokolRockville$62K
- Rachel SchreiberRockville$48K
- Julia SohnRockville$16K
- Nneoma ObiejembaRockville$11K
- Paul KeiserRockville$7K
- Jordana GoldmanRockville$6K
- Ryan BolotteRockville$4K
- Antoine AzarBaltimore$612K
- Mark ScarupaWheaton$508K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.